有価証券レコード · アーカイブ済み四半期
VRDN
Viridian Therapeutics, Inc. · Healthcare · Biotechnology
82追跡対象保有者
+2Δ保有者数
62.58M保有株数
$1.95B報告済み評価額
+4新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり +2.5% ·
株式フロー +26.3% ·
新規ネットポジション数 +3.7%
— 計算式
幅広い買い集め — より多くの保有者にわたって株式数が増加
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q4 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -12 | 71.65M | $1.32B | +6 | −18 |
| Q1 2026 | 88 | +7 | 66.96M | $1.32B | +11 | −5 |
| Q4 2025 | 82 | +2 | 62.58M | $1.95B | +4 | −1 |
| Q3 2025 | 16 | -1 | 34.97M | $754.70M | — | −1 |
| Q2 2025 | 14 | -2 | 33.44M | $467.46M | — | −2 |
| Q1 2025 | 13 | +2 | 10.47M | $141.20M | +2 | — |
| Q4 2024 | 11 | -2 | 10.88M | $208.63M | — | −2 |
| Q3 2024 | 12 | +3 | 5.78M | $131.57M | +3 | — |
| Q2 2024 | 9 | — | 3.15M | $40.97M | — | — |
保有者情報 · Q4 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.38M | +17.4% | $447.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 14.38M | +17.4% | $447.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 14.38M | +17.4% | $447.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 14.38M | +17.4% | $447.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | BlackRock ✦ (パッシブ) | 6.43M | +18.5% | $200.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | The Vanguard Group ✦ (パッシブ) | 5.61M | +29.6% | $174.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | The Vanguard Group ✦ (パッシブ) | 5.61M | +29.6% | $174.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | The Vanguard Group ✦ (パッシブ) | 5.61M | +29.6% | $174.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | The Vanguard Group ✦ (パッシブ) | 5.61M | +29.6% | $174.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | The Vanguard Group ✦ (パッシブ) | 5.61M | +29.6% | $174.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (パッシブ) | 3.47M | +35.7% | $107.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 3.44M | +42.2% | $107.04M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 3.44M | +42.2% | $107.04M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 27 | Geode Capital Management ✦ (パッシブ) | 1.99M | +12.8% | $62.01M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 28 | Geode Capital Management ✦ (パッシブ) | 1.99M | +12.8% | $62.01M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 32 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 33 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 34 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 35 | Wellington Management ✦ | 1.97M | +75.6% | $61.35M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 36 | Fisher Asset Management ✦ | 1.78M | +48.2% | $55.40M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 1.74M | +805.6% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Loomis Sayles & Co L P | 1.48M | — | $46.09M | 0.1% | n/c | 1 | SEC ↗ |
| 46 | Loomis Sayles & Co L P | 1.48M | — | $46.09M | 0.1% | n/c | 1 | SEC ↗ |
| 47 | Alliancebernstein L.P. | 1.41M | — | $44.01M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Marshall Wace ✦ | 1.38M | +58.3% | $42.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 49 | Marshall Wace ✦ | 1.38M | +58.3% | $42.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 50 | Goldman Sachs Group ✦ | 1.26M | +65.3% | $39.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 51 | Goldman Sachs Group ✦ | 1.26M | +65.3% | $39.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 52 | Jennison Associates Llc | 1.15M | — | $35.91M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 1.01M | +63.4% | $31.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 1.01M | +63.4% | $31.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 1.01M | +63.4% | $31.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 56 | JPMorgan Chase ✦ | 1.01M | +63.4% | $31.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 57 | D. E. Shaw & Co. ✦ | 1.00M | 新規 | $31.14M | 0.0% | New | 1 | SEC ↗ |
| 58 | D. E. Shaw & Co. ✦ | 1.00M | 新規 | $31.14M | 0.0% | New | 1 | SEC ↗ |
| 59 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Bank Of America Corp /De/ | 990.12K | — | $30.81M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | Pictet Asset Management Holding SA | 922.77K | — | $28.72M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | Adage Capital Partners ✦ | 790.02K | -35.2% | $24.59M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 67 | Charles Schwab Investment… | 748.96K | — | $23.31M | 0.0% | n/c | 1 | SEC ↗ |
| 68 | Nuveen, LLC | 742.34K | — | $23.10M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | Nuveen, LLC | 742.34K | — | $23.10M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | Nuveen, LLC | 742.34K | — | $23.10M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | Citadel Advisors ✦ | 679.69K | +778.5% | $21.15M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 72 | Citadel Advisors ✦ | 679.69K | +778.5% | $21.15M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 73 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 74 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 75 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 76 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 77 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 78 | Northern Trust Corp | 668.42K | — | $20.80M | 0.0% | n/c | 1 | SEC ↗ |
| 79 | Dimensional Fund Advisors Lp | 555.59K | — | $17.29M | 0.0% | n/c | 1 | SEC ↗ |
| 80 | Dimensional Fund Advisors Lp | 555.59K | — | $17.29M | 0.0% | n/c | 1 | SEC ↗ |
| 81 | Dimensional Fund Advisors Lp | 555.59K | — | $17.29M | 0.0% | n/c | 1 | SEC ↗ |
| 82 | Dimensional Fund Advisors Lp | 555.59K | — | $17.29M | 0.0% | n/c | 1 | SEC ↗ |
| 83 | Dimensional Fund Advisors Lp | 555.59K | — | $17.29M | 0.0% | n/c | 1 | SEC ↗ |
| 84 | Bnp Paribas Financial Markets | 517.40K | — | $16.10M | 0.0% | n/c | 1 | SEC ↗ |
| 85 | Balyasny Asset Management L.P. | 503.87K | — | $15.68M | 0.0% | n/c | 1 | SEC ↗ |
| 86 | Deutsche Bank Ag\ | 479.76K | — | $14.93M | 0.0% | n/c | 1 | SEC ↗ |
| 87 | Deutsche Bank Ag\ | 479.76K | — | $14.93M | 0.0% | n/c | 1 | SEC ↗ |
| 88 | Deutsche Bank Ag\ | 479.76K | — | $14.93M | 0.0% | n/c | 1 | SEC ↗ |
| 89 | Millennium Management ✦ | 460.12K | +237.6% | $14.32M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 90 | Federated Hermes, Inc. | 416.36K | — | $12.96M | 0.0% | n/c | 1 | SEC ↗ |
| 91 | Federated Hermes, Inc. | 416.36K | — | $12.96M | 0.0% | n/c | 1 | SEC ↗ |
| 92 | Arrowstreet Capital ✦ | 341.26K | 新規 | $10.62M | 0.0% | New | 1 | SEC ↗ |
| 93 | Raymond James Financial Inc | 303.77K | — | $9.42M | 0.0% | n/c | 1 | SEC ↗ |
| 94 | Raymond James Financial Inc | 303.77K | — | $9.42M | 0.0% | n/c | 1 | SEC ↗ |
| 95 | Raymond James Financial Inc | 303.77K | — | $9.42M | 0.0% | n/c | 1 | SEC ↗ |
| 96 | Jane Street Group, Llc | 279.61K | — | $8.70M | 0.0% | n/c | 1 | SEC ↗ |
| 97 | Jane Street Group, Llc | 279.61K | — | $8.70M | 0.0% | n/c | 1 | SEC ↗ |
| 98 | Jane Street Group, Llc | 279.61K | — | $8.70M | 0.0% | n/c | 1 | SEC ↗ |
| 99 | Point72 Asset Management ✦ | 254.28K | 新規 | $7.91M | 0.0% | New | 1 | SEC ↗ |
| 100 | Barclays Plc | 244.27K | — | $7.60M | 0.0% | n/c | 1 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| D. E. Shaw & Co. | $31.14M | 0.0% |
| D. E. Shaw & Co. | $31.14M | 0.0% |
| Arrowstreet Capital | $10.62M | 0.0% |
| Point72 Asset Management | $7.91M | 0.0% |
ポジション解消済み
| Two Sigma Investments | $474,997 | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 225 保有者, 111.32M 株式数, $2.12B 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Aug 19
Tousignant Jennifer
Officer · 4.21K 株 · $103,194
Aug 19
Tousignant Jennifer
Officer · 10.00K 株 · $245,000
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
Aug 20
SC 13G — Point72 Asset Management, L.P.
Aug 14
SC 13G/A — Paradigm Biocapital Advisors LP
Aug 14
SC 13G/A — Kynam Capital Management, LP
Aug 14
SC 13G/A — Deep Track Capital, LP
Aug 14
SC 13G — PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G — STATE STREET CORP
Jun 26
SC 13G — Paradigm Biocapital Advisors LP